What was NOCIL's revenue in Q4 FY26?

NOCIL reported revenue of ₹330 Cr in Q4 FY26, a — change year-over-year.

Did NOCIL management deliver on previous promises?

Scorecard data is being built as historical quarters are processed.

NOCIL Q4 FY26 Research Workspace: Revenue ₹330 Cr (—)

Q: What guidance did NOCIL management give?

Double-digit volume growth in FY27: Management targets double-digit volume growth for the coming year, building on Q4 momentum and new capacities.

Revenue ₹330 Cr

EBITDA ₹21 Cr

PAT ₹17 Cr

EBITDA Margin 6.4%

Duration 63 min

Read Time 1 min read

✓ Verified against BSE filing

2-Minute Summary

✦ AI-Generated from Full Transcript

NOCIL's Q4 FY26 revenue of ₹330 crore grew 5% sequentially, with volumes up 7% QoQ, driven by GST 2.0-led domestic demand and steady international traction. However, EBITDA margin contracted to 6.4% due to inventory effects and rising raw material costs, while PAT improved to ₹17 crore from ₹9 crore in Q3. Management expects double-digit volume growth in FY27, supported by new capacity at H (trial production started) and a ₹130 crore specialty capex for H1 FY28. Pricing power is returning: non-contractual prices were raised in March, and contractual revisions are underway. Anti-dumping duty recommendations for TDQ and sulfenamides await government approval, which could improve spreads. Key risk: persistent low-priced imports from FTA countries may delay margin recovery despite anti-dumping measures.

Risks4 trackedTranscriptfull text

Research workspace

Focused Modules

!Risks 4 risks

Risk Intelligence

Low-priced imports from FTA countries

View Risks →

≡Transcript Full text

Call Transcript

Full transcript text is available on this route.

Read Transcript →

Quarter Snapshot

Volume Index (Q1 FY20=100) 150

+7% QoQ

Volume index reached 150 for the second time in history, indicating strong sequential volume growth.

Domestic Volume Mix 70%

Flat YoY

Domestic volumes account for 70% of total volume; export 30%.

Specialty Mix Target 20%

+5pp vs current

Management targets specialty mix to reach 20% of revenue post new capex, up from current ~15%.

Anti-dumping Duty Recommendation ₹40/kg

Pending approval

DGTR recommended ₹40/kg duty on TDQ and sulfenamides; central government approval expected by mid-June.

Fast read

Guidance and risk preview

Top guidance Double-digit volume growth in FY27

Management targets double-digit volume growth for the coming year, building on Q4 momentum and new capacities.

Top risk Low-priced imports from FTA countries

Imports from Thailand and Korea under FTA continue to pressure realizations; management is highlighting the issue but no outcome yet.